Singapore to add HPV9 vaccine to national schedules in 2027
HPV9 will join Singapore’s childhood and adult immunisation schedules for eligible females from 1 January 2027. The ministry says covered HPV types are associated with about 90% of cervical cancers.
Event / data period: 2026-10-02
Published: · Updated:
Singapore’s Ministry of Health announced on 2 October that the nine-valent HPV vaccine, HPV9, will be added to the National Childhood Immunisation Schedule, National Adult Immunisation Schedule and Subsidised Vaccine List from 1 January 2027. The change covers eligible Singaporean and permanent-resident females aged 9–26; HPV2 will remain as an alternative. The ministry says HPV16 and HPV18 are associated with about 70% of cervical cancers, while additional types covered by HPV9 account for a further 20%, bringing the combined type coverage to about 90%.
The announcement recommends two doses for unvaccinated females who start at ages 9–14 and three doses for those who start at ages 15–26; an incomplete course may be finished after age 26 and up to age 45. Some secondary-school students who began with HPV2 in 2026 will receive HPV9 as their second dose in 2027. Type coverage is not a measure of vaccine efficacy or an individual’s probability of protection; additional HPV9 doses are not recommended for people who have completed a recommended course.
Data
Singapore’s HPV9 schedule and HPV-type coverage
Programme rules announced by the Ministry of Health on 2 October 2026 for 1 January 2027, plus the shares of cervical cancers associated with HPV types covered by the vaccines.
- Recommended doses for those starting HPV vaccination at ages 9–14
- 2 doses
- 2027-01-01 · Target
- Recommended doses for those starting HPV vaccination at ages 15–26
- 3 doses
- 2027-01-01 · Target
Methodology
The release’s 70% and further 20% figures are source estimates of the shares of cervical cancers associated with HPV types; they are not clinical vaccine efficacy or individual protection rates. The approximately 90% total describes the type coverage stated by the source. Dose counts are programme recommendations for unvaccinated females starting at the stated ages; prior vaccination and individual clinical circumstances require medical advice.
Updated:
Subjects and places
Subject proposals
- Communicable diseaseSuggested
- Subject suggested from the title or summary: HPV9www.moh.gov.sg ↗
- CancerSuggested
- Subject suggested from the title or summary: cancerswww.moh.gov.sg ↗
Geographic references
Only source-provided geographic references are shown. Opening an external map is optional. Optional story maps use OpenStreetMap. Opening a map sends your IP address and this site’s address to the map provider; location data remains readable as text without loading the map.
- Singapore · Place role: Coverage · Place type: Country or area · Location precision: RegionalEvidence
- Explicit preserved editorial country/region; no city or national centroid inferredwww.moh.gov.sg ↗
- Singapore · Singapore, Singapore · Place role: Place mentioned by source · Place type: City · Location precision: Approximate
103.862396307, 1.28716598445 (longitude, latitude)
EvidenceOpen this point in OpenStreetMap ↗- Explicit article mention: Singapore. Country agrees with the preserved article scope. Gazetteer reference only; event location is unconfirmed.www.moh.gov.sg ↗ungegn.un.org ↗ungegn-api.azurewebsites.net ↗